Anne Marie Falk

Array ( [id] => 5776318 [patent_doc_number] => 20060104958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Tissue engineered cardiac constructs' [patent_app_type] => utility [patent_app_number] => 11/265515 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7899 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104958.pdf [firstpage_image] =>[orig_patent_app_number] => 11265515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842182 [patent_doc_number] => 20060121013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Use of negative regulatory elements for the neurospecific expression of transgenes' [patent_app_type] => utility [patent_app_number] => 11/256112 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10114 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121013.pdf [firstpage_image] =>[orig_patent_app_number] => 11256112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5636962 [patent_doc_number] => 20060067935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/199374 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11538 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20060067935.pdf [firstpage_image] =>[orig_patent_app_number] => 11199374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254314 [patent_doc_number] => 20100138935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Detection of cellular stress' [patent_app_type] => utility [patent_app_number] => 11/572152 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17341 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20100138935.pdf [firstpage_image] =>[orig_patent_app_number] => 11572152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5532983 [patent_doc_number] => 20090232771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Method of controlling cell functions' [patent_app_type] => utility [patent_app_number] => 11/632459 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25863 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232771.pdf [firstpage_image] =>[orig_patent_app_number] => 11632459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5774675 [patent_doc_number] => 20050268350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Identification and purification of higher order transcription complexes from transgenic non-human animals' [patent_app_type] => utility [patent_app_number] => 11/137671 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13166 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20050268350.pdf [firstpage_image] =>[orig_patent_app_number] => 11137671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110648 [patent_doc_number] => 20050208103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Targeted transscleral controlled release drug delivery to the retina and choroid' [patent_app_type] => utility [patent_app_number] => 11/124949 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9503 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208103.pdf [firstpage_image] =>[orig_patent_app_number] => 11124949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670860 [patent_doc_number] => 20080045920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Method Of Constructing Animal Model Suffereing From Left Ventricular Diastolic Disorder For Examining Heart Failure And Method Of Examining Remedy For Heart Failure Caused By Left Ventricular Diastolic Failure With The Use Of The Animal Model' [patent_app_type] => utility [patent_app_number] => 11/568501 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5839 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045920.pdf [firstpage_image] =>[orig_patent_app_number] => 11568501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6958497 [patent_doc_number] => 20050214867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Prion protein standard and method of making same' [patent_app_type] => utility [patent_app_number] => 11/114859 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14379 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214867.pdf [firstpage_image] =>[orig_patent_app_number] => 11114859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6979940 [patent_doc_number] => 20050289658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'System for regulating in vivo the expression of a transgene by conditional inhibition' [patent_app_type] => utility [patent_app_number] => 11/106674 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 21937 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0289/20050289658.pdf [firstpage_image] =>[orig_patent_app_number] => 11106674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216469 [patent_doc_number] => 20050260164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Gene regulation with aptamer and modulator complexes for gene therapy' [patent_app_type] => utility [patent_app_number] => 11/102428 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22536 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260164.pdf [firstpage_image] =>[orig_patent_app_number] => 11102428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243057 [patent_doc_number] => 20050257280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide' [patent_app_type] => utility [patent_app_number] => 11/059275 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8589 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20050257280.pdf [firstpage_image] =>[orig_patent_app_number] => 11059275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945262 [patent_doc_number] => 20050197311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Compositions and methods for detecting intracellular glucose and analogs thereof' [patent_app_type] => utility [patent_app_number] => 11/054024 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 37614 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197311.pdf [firstpage_image] =>[orig_patent_app_number] => 11054024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 119653 [patent_doc_number] => RE041286 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-04-27 [patent_title] => 'Compositions for regeneration and repair of cartilage lesions' [patent_app_type] => reissue [patent_app_number] => 11/046674 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 31562 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041286.pdf [firstpage_image] =>[orig_patent_app_number] => 11046674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7100959 [patent_doc_number] => 20050132426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Long-term cell culture compositions and genetically modified animals derived therefrom' [patent_app_type] => utility [patent_app_number] => 11/041152 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 10501 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20050132426.pdf [firstpage_image] =>[orig_patent_app_number] => 11041152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769432 [patent_doc_number] => 20050265977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Xenotransplant for CNS therapy' [patent_app_type] => utility [patent_app_number] => 11/036202 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15174 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265977.pdf [firstpage_image] =>[orig_patent_app_number] => 11036202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020009 [patent_doc_number] => 20050222028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'BMP-9 compositions and methods for inducing differentiation of cholinergic neurons' [patent_app_type] => utility [patent_app_number] => 11/011791 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6037 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222028.pdf [firstpage_image] =>[orig_patent_app_number] => 11011791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7039421 [patent_doc_number] => 20050158855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 11/010230 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19056 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158855.pdf [firstpage_image] =>[orig_patent_app_number] => 11010230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62674 [patent_doc_number] => 07763463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 11/009504 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15588 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763463.pdf [firstpage_image] =>[orig_patent_app_number] => 11009504 [rel_patent_id] =>[rel_patent_doc_number] =>)